Literature DB >> 17186393

Paper-based dosing algorithms for maintenance of warfarin anticoagulation.

Sarah E Wilson1, Lorrie Costantini, Mark A Crowther.   

Abstract

We examined the quality of anticoagulation produced by two paper-based warfarin dosing algorithms in a randomized clinical trial of warfarin therapy. Fifty-eight patients were randomized to receive warfarin at a target international normalized ratio (INR) range of 2.1-3.0 and were followed for an average of 2.7 years. As a proportion of total patient-time, the percentage of time spent above, within, and below the therapeutic range was 11%, 71%, and 19% respectively. Fifty-six patients were randomized to receive warfarin at a higher target INR range (3.1-4.0) and had INRs within the therapeutic range for 40% of total patient time. We conclude that the performance, minimal cost, and ease-of-use of these algorithms make them well-suited for patient management within primary-care and research settings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17186393     DOI: 10.1007/s11239-006-9025-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  13 in total

1.  A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.

Authors:  Mark A Crowther; Jeff S Ginsberg; Jim Julian; Judah Denburg; Jack Hirsh; James Douketis; Carl Laskin; Paul Fortin; David Anderson; Clive Kearon; Ann Clarke; William Geerts; Melissa Forgie; David Green; Lorrie Costantini; Wendy Yacura; Sarah Wilson; Michael Gent; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

2.  Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic disease.

Authors:  M J Kovacs; M Cruickshank; P S Wells; H Kim; I Chin-Yee; B Morrow; E Boyle; J Kovacs
Journal:  Haemostasis       Date:  1998 Mar-Apr

3.  A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients.

Authors:  J Gedge; S Orme; K K Hampton; K S Channer; T J Hendra
Journal:  Age Ageing       Date:  2000-01       Impact factor: 10.668

4.  Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities.

Authors:  G P Samsa; D B Matchar; L B Goldstein; A J Bonito; L J Lux; D M Witter; J Bian
Journal:  Arch Intern Med       Date:  2000-04-10

5.  Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.

Authors:  B S Hellemons; M Langenberg; J Lodder; F Vermeer; H J Schouten; T Lemmens; J W van Ree; J A Knottnerus
Journal:  BMJ       Date:  1999-10-09

6.  The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Jack Ansell; Jack Hirsh; Leon Poller; Henry Bussey; Alan Jacobson; Elaine Hylek
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

7.  Warfarin, aspirin, or both after myocardial infarction.

Authors:  Mette Hurlen; Michael Abdelnoor; Pål Smith; Jan Erikssen; Harald Arnesen
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

8.  Risk of major hemorrhage for outpatients treated with warfarin.

Authors:  D A McMahan; D M Smith; M A Carey; X H Zhou
Journal:  J Gen Intern Med       Date:  1998-05       Impact factor: 5.128

9.  A method to determine the optimal intensity of oral anticoagulant therapy.

Authors:  F R Rosendaal; S C Cannegieter; F J van der Meer; E Briët
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

10.  A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation.

Authors:  P T Sawicki
Journal:  JAMA       Date:  1999-01-13       Impact factor: 56.272

View more
  4 in total

1.  Pharmacogenomic trial design: use of a PK/PD model to explore warfarin dosing interventions through clinical trial simulation.

Authors:  David H Salinger; Danny D Shen; Kenneth Thummel; Ann K Wittkowsky; Paolo Vicini; David L Veenstra
Journal:  Pharmacogenet Genomics       Date:  2009-12       Impact factor: 2.089

2.  A team-based approach to warfarin management in long term care: a feasibility study of the MEDeINR electronic decision support system.

Authors:  Alexandra Papaioannou; Courtney C Kennedy; Glenda Campbell; Jacqueline B Stroud; Luqi Wang; Lisa Dolovich; Mark A Crowther
Journal:  BMC Geriatr       Date:  2010-06-10       Impact factor: 3.921

3.  A systems approach to designing effective clinical trials using simulations.

Authors:  Vincent A Fusaro; Prasad Patil; Chih-Lin Chi; Charles F Contant; Peter J Tonellato
Journal:  Circulation       Date:  2012-12-21       Impact factor: 29.690

4.  Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review.

Authors:  Madeleine Verhovsek; Bahareh Motlagh; Mark A Crowther; Courtney Kennedy; Lisa Dolovich; Glenda Campbell; Luqi Wang; Alexandra Papaioannou
Journal:  BMC Geriatr       Date:  2008-07-03       Impact factor: 3.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.